IRTC - Irhythm Holdings, Inc.

Insider Sale by Rosenbaum Marc Wade (Chief Accounting Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Rosenbaum Marc Wade, serving as Chief Accounting Officer at Irhythm Holdings, Inc. (IRTC), sold 816 shares at $128.45 per share, for a total transaction value of $104,815.00. Following this transaction, Rosenbaum Marc Wade now holds 16,706 shares of IRTC.

This sale represents a 5.00% decrease in Rosenbaum Marc Wade's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Irhythm Holdings, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Rosenbaum Marc Wade

Chief Accounting Officer

Marc Wade Rosenbaum is the Chief Accounting Officer at iRhythm Technologies, Inc. (NASDAQ: IRTC), a company specializing in cardiac monitoring solutions.[[1]](https://www.investing.com/news/insider-trading-news/irhythm-holdings-cao-rosenbaum-sells-39k-in-shares-93CH-4526272)[[2]](https://www.quiverquant.com/news/Insider+Sale:+Chief+Accounting+Officer+of+$IRTC+Sells+4,797+Shares)[[4]](https://www.stocktitan.net/sec-filings/IRTC/form-4-i-rhythm-holdings-inc-insider-trading-activity-a04262c2fe9d.html) In this role, he oversees accounting functions and has been involved in recent insider transactions, including selling 280 shares on February 24, 2026, at $140.91 per share for approximately $39,454 under a Rule 10b5-1 trading plan,[[1]](https://www.investing.com/news/insider-trading-news/irhythm-holdings-cao-rosenbaum-sells-39k-in-shares-93CH-4526272)[[7]](http://openinsider.com/insider/Rosenbaum-Marc-Wade/1929535) and selling 4,797 shares on February 25, 2026, at $135.42 per share for about $649,610 to cover tax obligations on vesting restricted stock units (RSUs).[[2]](https://www.quiverquant.com/news/Insider+Sale:+Chief+Accounting+Officer+of+$IRTC+Sells+4,797+Shares)[[4]](https://www.stocktitan.net/sec-filings/IRTC/form-4-i-rhythm-holdings-inc-insider-trading-activity-a04262c2fe9d.html)[[8]](https://www.investing.com/news/insider-trading-news/irtc-irhythms-rosenbaum-sells-649k-in-stock-93CH-4530095)[[10]](https://www.marketbeat.com/instant-alerts/insider-selling-irhythm-technologies-nasdaqirtc-cao-sells-4797-shares-of-stock-2026-02-26/) He also received 9,210 RSUs on February 24, 2026, resulting in direct ownership of 15,014 shares post-transactions.[[4]](https://www.stocktitan.net/sec-filings/IRTC/form-4-i-rhythm-holdings-inc-insider-trading-activity-a04262c2fe9d.html) Rosenbaum has a history of prior sales, such as 226 shares on August 11, 2025, at $158.93,[[5]](https://finviz.com/insidertrading?oc=1929535)[[6]](https://unusualwhales.com/stock/IRTC/insiders/rosenbaum-marc-wade)[[9]](https://stockcircle.com/insider-trades/person/rosenbaum-marc-wade) and earlier grants like on November 28, 2025.[[3]](https://www.insidearbitrage.com/insider-transactions/insider/0001929535/rosenbaum-marc-w/) His ongoing share ownership reflects approximately $1.97 million in value as of recent filings.[[9]](https://stockcircle.com/insider-trades/person/rosenbaum-marc-wade)

View full insider profile →

Trade Price

$128.45

Quantity

816

Total Value

$104,815.00

Shares Owned

16,706

Trade Date

Monday, March 2, 2026

3 days ago

SEC Filing Date

Tuesday, March 3, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Irhythm Holdings, Inc.

Company Overview

No company information available
View news mentioning IRTC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4470957

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime